Physician profile
Dongjun Jeong
NPI 1871844423
$6,839.08
in general payments reported to CMS, 2019-2025
7 companies · $6,161 in 2025
The $6,161 reported for 2025 was more than what 99% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.49 · 2020: $14.54 · 2022: $14.36 · 2023: $618 · 2025: $6,161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,000 · Food and Beverage: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,000.00 |
| Food and Beverage | $778.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Envista Holdings Corporation | $6,020.75 | 2025 | Education, Zirconia Abutment Preparation Kit |
| Ivoclar Vivadent, INC. | $310.06 | 2023 | |
| Nobel Biocare USA | $175.36 | 2019-2023 | Nobelactive |
| Gc America INC. | $139.87 | 2025 | Gc Initial, Cerasmart, Equia |
| Ormco Corporation | $128.74 | 2023 | Nobelparallel |
| Dentsply Sirona INC | $35.40 | 2019-2023 | Cavitron |
| Orapharma, A Division of Bausch Health US, LLC | $28.90 | 2020-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dongjun Jeong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.